GSK
GSK | NYSE
$49.78
-$0.94 (-1.85%)
At close: Sep 23, 2026, 3:43 PM ET
$49.65
-$0.13 (-0.26%)
Pre-market:
Sep 24, 2026, 5:51 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 3.09B | 4.54B | 3.39B | 4.44B | 4.93B | 5.76B | 3.69B | 3.19B | 3.74B | 3.52B | 3.74B | 3.88B | 3.99B | 3.57B | 3.72B | 4.03B | 7.85B | 4.9B | 5.79B | 4.66B | 4.84B | 6.56B |
Short-Term Investments | 993.96K | 1.32M | 8.98M | 10M | 27.41M | 27.11M | 21M | 20M | 26.55M | 1.65B | 2.86B | 4.28B | 4.28B | 5.05B | 4.15B | 3.97B | 81.37M | 5.47B | 82.62M | 82.25M | 81.51M | 82.78M |
Long-Term Investments | 966.13M | 1.29B | 1.12B | 1.46B | 1.34B | 1.33B | 1.21B | 1.11B | 1.46B | 1.61B | 2.73B | 1.39B | 1.72B | 1.66B | -2.61B | 1.83B | 2.11B | 2.03B | 4.29B | 3.81B | 4.48B | 5.19B |
Other Long-Term Assets | 2.64B | 3.11B | 2.14B | 2.87B | 2.74B | 2.61B | 1.93B | 1.94B | 2.18B | 2.09B | 808.22M | 1.4B | 1.78B | 1.85B | 5.35B | 1.31B | 2.11B | 1.57B | 1B | 1.68B | 1.57B | 1.36B |
Receivables | 8.03B | 10.47B | 7.75B | 11.18B | 10.55B | 9.68B | 6B | 7.38B | 9.83B | 9.21B | 9.44B | 10.83B | 9.02B | 8.81B | 6.22B | 9.04B | 8.34B | 9.82B | 10.88B | 11.17B | 10.37B | 9.91B |
Inventory | 6.24B | 8.12B | 5.91B | 8.24B | 8.32B | 7.74B | 5.67B | 5.92B | 7.41B | 7.2B | 7.01B | 6.69B | 7.01B | 6.62B | 5.15B | 5.2B | 5.66B | 6.78B | 7.83B | 8.42B | 8.74B | 8.58B |
Other Current Assets | 96.42M | 295.39M | 420.26M | 153.47M | 390.55M | 127.78M | 1.23B | 785M | 182.03M | 147.8M | 262.61M | 247.77M | 301.31M | 321.48M | 1.1B | 373.96M | 43.87B | 379.2M | 284.44M | 285.85M | 230.7M | 424.95M |
Total Current Assets | 17.45B | 23.42B | 17.48B | 24.02B | 24.22B | 23.34B | 17B | 17.3B | 21.19B | 21.73B | 23.77B | 25.92B | 24.6B | 24.38B | 20.77B | 22.6B | 65.81B | 27.35B | 25.29B | 24.61B | 24.27B | 25.56B |
Property-Plant & Equipment | 9.97B | 13.24B | 10.03B | 13.64B | 13.59B | 12.87B | 10.07B | 9.73B | 12.42B | 12.46B | 12.69B | 11.54B | 11.84B | 11.64B | 9.62B | 10.77B | 11.12B | 12.67B | 14.45B | 14.38B | 14.63B | 14.67B |
Goodwill & Intangibles | 24.04B | 33.53B | 23.72B | 32.29B | 30.3B | 29.92B | 22.5B | 21.69B | 28.36B | 28.61B | 27.51B | 27.18B | 28.28B | 25.99B | 21.36B | 25.43B | 20.98B | 28.13B | 55.03B | 55.04B | 54.94B | 54.99B |
Total Long-Term Assets | 43.91B | 59.48B | 43.53B | 58.56B | 56.99B | 55.01B | 42.47B | 40.75B | 52.21B | 52.18B | 51.45B | 48.36B | 51B | 48.07B | 39.38B | 44.72B | 42.33B | 51.85B | 81.85B | 81.49B | 82.12B | 82.17B |
Total Assets | 61.37B | 82.91B | 61.01B | 82.58B | 81.2B | 78.35B | 59.46B | 58.05B | 73.4B | 73.91B | 75.22B | 74.29B | 75.6B | 72.45B | 60.15B | 67.33B | 108.14B | 79.19B | 107.14B | 106.1B | 106.39B | 107.73B |
Account Payables | 14.26B | 18.9B | 15.35B | 15.68B | 20.31B | 19.55B | 3.46B | 14.38B | 18.01B | 18.47B | 20.2B | 19.02B | 17.74B | 17.64B | 3.87B | 17.99B | 17.98B | 21.41B | 6.14B | 20.54B | 19.71B | 20.16B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 415.82M | n/a | n/a | n/a |
Short-Term Debt | 4.27B | 6.65B | 3.01B | 3.84B | 2.81B | 2.53B | 2.18B | 2.82B | 4.25B | 3.3B | 3.59B | 5.91B | 7.53B | 5.27B | 3.79B | 3.12B | 4.04B | 5.2B | 4.88B | 6.57B | 6.96B | 4.38B |
Other Current Liabilities | 2.36B | 3.29B | 2.5B | 8.88B | 4.01B | 4B | 14.76B | 3.7B | 2.53B | 2.39B | 2.22B | 2.05B | 2.15B | 2.16B | 14.1B | 2.14B | 23.57B | 2.8B | 17.97B | 2.16B | 2.3B | 2.53B |
Total Current Liabilities | 21.4B | 29.58B | 21.35B | 28.72B | 27.92B | 26.89B | 21.7B | 21.46B | 25.72B | 25.07B | 26.86B | 27.33B | 28.11B | 25.59B | 22.81B | 23.39B | 45.95B | 30.03B | 32.06B | 30.23B | 29.55B | 27.97B |
Long-Term Debt | 13.86B | 18.48B | 14.68B | 20.05B | 20.97B | 21.26B | 13.7B | 13.24B | 17.16B | 19.15B | 18.04B | 19.52B | 19.77B | 20.58B | 16.19B | 21.57B | 22.81B | 22.43B | 26.76B | 27.96B | 28.24B | 31.8B |
Other Long-Term Liabilities | 8.72B | 11.49B | 8.69B | 12.07B | 12.11B | 12.06B | 9.5B | 9.6B | 12.75B | 12.62B | 11.95B | 11.54B | 11.62B | 11.94B | 9.83B | 12.23B | 11.7B | 13.06B | 13.38B | 13.65B | 13.84B | 14.05B |
Total Long-Term Liabilities | 22.89B | 30.35B | 23.66B | 32.65B | 33.61B | 33.84B | 24.68B | 23.14B | 30.28B | 32.13B | 32.05B | 31.55B | 32.03B | 32.87B | 27.24B | 34.21B | 34.7B | 35.87B | 46.17B | 46.55B | 47.03B | 50.76B |
Total Liabilities | 44.29B | 59.93B | 45.02B | 61.37B | 61.53B | 60.73B | 46.38B | 44.6B | 55.99B | 57.2B | 58.91B | 58.88B | 60.14B | 58.46B | 50.05B | 57.6B | 80.65B | 65.9B | 78.23B | 76.78B | 76.58B | 78.74B |
Total Debt | 18.13B | 25.13B | 17.69B | 23.9B | 23.78B | 23.79B | 16.99B | 16.06B | 21.42B | 22.45B | 22.97B | 25.43B | 27.3B | 25.85B | 20.99B | 24.69B | 26.85B | 27.63B | 32.74B | 34.52B | 35.2B | 36.17B |
Book Value | 17.07B | 22.97B | 15.99B | 21.21B | 19.67B | 17.62B | 13.09B | 13.45B | 17.41B | 16.71B | 16.31B | 15.4B | 15.46B | 13.99B | 10.1B | 9.73B | 27.5B | 13.29B | 28.91B | 29.32B | 29.81B | 28.99B |
Book Value Per Share | 8.41 | 11.28 | 7.83 | 10.34 | 9.57 | 8.52 | 6.31 | 6.59 | 8.45 | 8.13 | 7.92 | 7.49 | 7.55 | 6.85 | 4.94 | 4.76 | 13.53 | 6.54 | 14.19 | 14.47 | 14.76 | 14.39 |
Common Stock | 1.34B | 1.78B | 1.35B | 1.82B | 1.85B | 1.74B | 1.35B | 1.35B | 1.7B | 1.7B | 1.72B | 1.65B | 1.71B | 1.67B | 1.35B | 1.5B | 1.64B | 1.77B | 1.82B | 1.82B | 1.86B | 1.86B |
Retained Earnings | 11.39B | 15.28B | 10.19B | 13.48B | 12.05B | 10.72B | 7.8B | 8.19B | 10.85B | 10.02B | 9.23B | 8.56B | 8.16B | 6.99B | 4.36B | 2.89B | 11.93B | 5.74B | 13.26B | 10.49B | 10.19B | 9.24B |
Comprehensive Income | 1.32B | 1.86B | n/a | 1.75B | 1.59B | 1.31B | n/a | 1B | 1.22B | 1.37B | 2.04B | 1.61B | 1.88B | 1.69B | n/a | 1.98B | 2.14B | 1.91B | 869.56M | 4.04B | 4.76B | 5.05B |
Shareholders Equity | 17.54B | 23.54B | 16.35B | 21.74B | 20.27B | 18.27B | 13.67B | 14.01B | 18.17B | 17.48B | 17.01B | 16.03B | 16.13B | 14.61B | 10.6B | 10.22B | 19.89B | 13.95B | 20.39B | 20.8B | 21.24B | 20.51B |
Total Investments | 967.13M | 1.29B | 1.13B | 1.47B | 1.37B | 1.36B | 1.23B | 1.12B | 1.48B | 3.26B | 5.59B | 5.67B | 5.99B | 6.71B | 1.54B | 5.8B | 2.19B | 7.5B | 4.37B | 3.89B | 4.56B | 5.27B |
Add to Watchlist
Select watchlists to add or remove GSK